Open Label Phase 2 Study of Tisotumab Vedotin for Locally Advanced or Metastatic Disease in Solid Tumors

IRB/UVA Tracking #
21158
Contact
Contact Phone
Phase
II
Primary purpose
Treatment
Cancer PI
Matthew Reilley
Status
OPEN TO ACCRUAL
Ages
Adult